In this review, we focus on the association of gene and protein of apoA5 with obesity and metabolic syndrome, and provide new insights into the physiological role of apoA5 in humans, giving a potential therapeutic target for obesity and associated disorders. Here, APOA5 is linked to obesity due to melanocortin 4 receptor deficiency.